Former Lab Members

Name
Degree
Research Project
Current Position
Rita Alisauskas
Ph.D.
Monoclonal antibodies for therapy of murine lymphomas
Professor of Biology, County College of Morris, New Jersey
Alice Alonso
Ph.D.
Production of autoantibodies against tumor activated lymphocytes
Principal Scientist,  Interventional Therapies, Cordis Corporation, Warren, NJ
Hani Batarseh
M.D.
Use of umbilical cord blood cells for cancer immunotherapy
Royal Medical Services, Amman, Jordan
Michael Buckley
Ph.D.
Mechanisms of chronic murine Ig allotype suppression
Vice President of Manufacturing; Genitope Corp; Redwood City, CA
Scott Cutro
M.D. Tumor-responsive T cell clones PGY2 Resident; Emory Univ Hospital; Atlanta, GA
Janine Delmanto-Wajchman
Ph.D.
Influence of IL-12 on host response to syngeneic B cell lymphomas
Assistant Professor; Georgian Court College; Toms River, NJ 
Greg Erianne
Ph.D.
Characterization of B cell lymphomas in C57L mice
Professor, Naugatuck Valley Community College, Waterbury, CT
Helen Fernandes
Ph.D.
Influence of monoclonal antibody therapy on B cell lymphoma growth
Associate Professor, Scientific Director of Molecular Diagnosis, Department of Pathology & Laboratory Medicine, UMDNJ-New Jersey Medical School
Karen Fitzgerald
Ph.D.
Natural killer cell activity in murine lymphomas
Program Director; Hospira, Inc.  
Lake Forest, IL
Andrew Klein
M.D.
Analysis of tumor-activated T cells
Advanced Cardiology Research Fellow, University of Wisconsin, Madison, WI
Mythili Koneru
Ph.D.
Use of umbilical cord blood for adoptive immunotherapy
PGY1 Resident; Montefiore Hospital; New York, NY
Alfred Murdock (Tersh)
D.O.
Natural Killer cell activity in SJL B cell lymphomas
Family Medicine, Overlook Hospital, Summit, NJ
Pranela Rameshwar
Ph.D.
Immunoglobulin allotype suppression
Professor, Department of Medicine, UMDNJ-New Jersey Medical School
William Simmons
Ph.D.
Immunotherapy with lymphoma-specific T helper-1 cells
Associate; Law offices of Sughrue Mion; Washington, DC (speciatly in patent law)
Howard Wajchman
Ph.D.
Analysis of tumor-activated T cells
CEO/President AARoN Immunotechnologies Laboratories, Atlanta, GA
Robert Yauch
Ph.D.
Monoclonal antibodies against tumor-activated T cells
Scientist in Mjolecular Diagnostics, Genentech, Inc.,  San Francisco, CA
Tao Zhen Lin
M.D.
Role of NK cells in growth and development of B cell lymphomas
Senior Research Associate, Department of Pathology & Laboratory Medicine, UMDNJ-New Jersey Medical School